by Vora Corporate Finance | May 28, 2021 | Financial Advisory, Insights, Merger & Acquisitions, Private Equity & IPO
Indian Economy’s recovery pace moderated in April on account of 2nd Covid-19 wave with record infections. Markets remained stable in this month but two IPOs were listed at discount. Key Deals include BYJU’S to acquire Aakash, Piramal to Acquire Hemmo Pharmaceuticals...
by Vora Corporate Finance | May 21, 2021 | Financial Advisory, Insights, Merger & Acquisitions
Transaction: Piramal Pharma Limited to acquire a 100% stake in Hemmo Pharmaceuticals Pvt. Ltd. for an upfront consideration of Rs.775 crores and earn-outs linked to achievement of milestones. Consequent to this acquisition, Hemmo will become a wholly owned subsidiary...
by Vora Corporate Finance | May 20, 2021 | Financial Advisory, Insights, Private Equity & IPO
Transaction: Creador sold its stake in Ahmedabad based Corona Remedies to PE fund ChrysCapital. ChrysCapital paid Rs.6.7 billion ($90 million) for a 30% stake, of which 20% came from Creador and 10% from the promoter group. The deal values Corona Remedies at around...
by Vora Corporate Finance | May 18, 2021 | Financial Advisory, Insights, Merger & Acquisitions
Transaction: BYJU’S has announced to acquire Aakash Educational Services Limited (AESL) through a strategic merger in a nearly $1 Billion deal. Aakash founders JC Chaudhry and Aakash Chaudhry will continue to lead AESL’s growth and expansion. Aakash founders along...
by Vora Corporate Finance | May 18, 2021 | Articles, Capital Market Updates, Debt Syndication, Merger & Acquisitions, Private Equity & IPO
Capital Market quarterly update of Q4 FY21 published in the ACAE Kolkata (Association of Corporate Advisors & Executives) Journal in April 2021. The new year 2021 has begun on a strong positive note with vaccination drives in major economies as well as in India....
